terfenadine has been researched along with Fatty Liver in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raveendran, VV | 1 |
Kassel, KM | 1 |
Smith, DD | 1 |
Luyendyk, JP | 1 |
Williams, KJ | 1 |
Cherian, R | 1 |
Reed, GA | 1 |
Flynn, CA | 1 |
Csanaky, IL | 1 |
Lickteig, AL | 1 |
Pratt-Hyatt, MJ | 1 |
Klaassen, CD | 1 |
Dileepan, KN | 1 |
1 other study available for terfenadine and Fatty Liver
Article | Year |
---|---|
H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Ca | 2014 |